{"schema_version":"secwatch.filing_event.v1","accession":"0000872589-26-000023","form_type":"8-K","ticker":"REGN","cik":"0000872589","company_name":"REGENERON PHARMACEUTICALS, INC.","filed_at":"2026-07-30T10:48:32+00:00","discovered_at":"2026-07-30T10:50:00.296051+00:00","generated_at":"2026-07-30T10:50:06.807416+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Regeneron Q2 2026 revenue up 17% to $4.3B; non-GAAP EPS $14.29 beats; Dupixent sales up 38%","bullets":["Total revenues $4.291B (+17% YoY); GAAP EPS $12.23 (incl. $1.02 IPR&D charge); non-GAAP EPS $14.29 (+11%).","Dupixent global net sales (Sanofi) up 38% to $6.0B; EYLEA HD U.S. net sales up 52% to $596M; Libtayo global up 30% to $489M.","Sanofi Development Balance fully repaid; collaboration profits to step up in Q3. Guidance raised: GAAP gross margin 78-79% (prior 77-78%).","Cemdisiran NDA accepted for gMG with priority review; FDA target action date Nov 2026.","Share repurchases $1.2B in Q2; $2.0B in H1; dividend $0.94/share declared."],"urls":{"canonical":"https://secwatch.observer/filing/0000872589-26-000023","json":"https://secwatch.observer/filing/0000872589-26-000023.json","markdown":"https://secwatch.observer/filing/0000872589-26-000023.md","text":"https://secwatch.observer/filing/0000872589-26-000023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/872589/000087258926000023/0000872589-26-000023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/872589/000087258926000023/regn-20260730.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-30T10:50:06.807416+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}